Charles Sander is listed as an executive officer and director on 3 SEC Form D filings by 2 issuers between Nov 2013 and Jan 2020: Next Frontier Biosciences, Inc. (Westminster, CO — other health care — 2020; $2.85M reported sold to 27 investors) and Managed Methods, Inc. (Boulder, CO — computers — 2013–2014; $2M reported sold to 6 investors).
What this means 2 separate companies raised money with this person listed as executive officer and director, over about 7 years. Across those companies the filings report $4.85M sold in total.
Listed alongside Al Aghili (2 shared filings), Don Bergal (1 shared filing), James Kreitman (1 shared filing), Marc Graboyes (1 shared filing), Paul Johnson (1 shared filing) and 1 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Charles. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 bankruptcy case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 3 public filings for Charles Sander and found 2 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "Charles Sander" (HI) is a separate record.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.